Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Dan sell pumper buy.
View:
Post by StockingUp21 on Jun 08, 2021 12:39pm

Dan sell pumper buy.

And they thank him for it. Bizarre here.
Comment by Hideaway on Jun 08, 2021 12:46pm
The optics are terrible when CEO and Board member sell some of their shares.This is especially so when we are hoping for a catalyst to move our SP. 
Comment by IrishCanuck on Jun 08, 2021 12:47pm
Don't be upset with us your average buy price must be $6.00 and you're sweating being in the red... 
Comment by StockingUp21 on Jun 08, 2021 2:00pm
So you not upset with delay, no deal, no volume insider selling, no nasdaqq,no institution. Typical pumper here.   
Comment by MrMugsy on Jun 08, 2021 2:17pm
StockingUp ... I think your timing is off a little so I wouldn't take it out on Irish. Trying for deals before Phase 3 - I still consider that on track but it could easily push out.  Depends how talks go. No NASDAQ - that has been indicated as likely a Fall thing. Institutional buying - I relate that to the amalgamation, the NASDAQ and sone real news to drive it (like deals). Volume - ...more  
Comment by IrishCanuck on Jun 08, 2021 2:28pm
Delay - Oh so you literally have no concept of time for how long clinical trials take and where we are in the process to call this delayed? Plus impacts of COVID and clear startegy has been communicated by Antibe...  No deal - You also have zero concept of the deals Antibe has signed in the past or that negotiations take time... you'd sign the USA rights for four million ...more  
Comment by GameChangerBet on Jun 08, 2021 3:33pm
You're speaking in terms of next level thinking and forward outlook, which unfortuantely, some on here don't have the capacity to understand, and I've said before, the simple lack of market education is why most retail investors will ride stocks down to zero. There is a market rotation in full effect currently, there has been for a few months, out of high tech, out of health care ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities